Resisting medicines: a synthesis of qualitative studies of medicine taking
The study aimed to synthesise qualitative studies of lay experiences of medicine taking.
Most studies focused on the experience of those not taking their medicine as prescribed …
Most studies focused on the experience of those not taking their medicine as prescribed …
[HTML][HTML] Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators
Background Adherence to highly active antiretroviral therapy (HAART) medication is the
greatest patient-enabled predictor of treatment success and mortality for those who have …
greatest patient-enabled predictor of treatment success and mortality for those who have …
Factors affecting adherence to antiretroviral therapy
MA Chesney - Clinical Infectious Diseases, 2000 - academic.oup.com
In both clinical trials and clinical practice, nonadherence to medications is widespread
among patients with chronic diseases. The shift to combination therapies for treating human …
among patients with chronic diseases. The shift to combination therapies for treating human …
Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection
BACKGROUND: There is little evidence to support the widely accepted assertion that better
physician-patient relationships result in higher rates of adherence with recommended …
physician-patient relationships result in higher rates of adherence with recommended …
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
S Staszewski, J Morales-Ramirez… - … England Journal of …, 1999 - Mass Medical Soc
Background Efavirenz is a nonnucleoside reverse-transcriptase inhibitor of human
immunodeficiency virus type 1 (HIV-1). We compared two regimens containing efavirenz …
immunodeficiency virus type 1 (HIV-1). We compared two regimens containing efavirenz …
Adherence to HAART regimens
M Chesney - AIDS patient care and STDs, 2003 - liebertpub.com
The problem of inadequate adherence to prescribed highly active antiretroviral therapy
(HAART) drug regimens to treat HIV infection and AIDS is ubiquitous. Adherence can be …
(HAART) drug regimens to treat HIV infection and AIDS is ubiquitous. Adherence can be …
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach
B Spire, S Duran, M Souville, C Leport, F Raffi… - Social science & …, 2002 - Elsevier
To-date, most socio-behavioural research about HIV-infected patients' adherence to highly
active antiretroviral therapies (HAART) has been based on cross-sectional studies. The …
active antiretroviral therapies (HAART) has been based on cross-sectional studies. The …
The language of medication-taking
JF Steiner, MA Earnest - Annals of internal medicine, 2000 - acpjournals.org
The Language of Medication-Taking | Annals of Internal Medicine Advertisement ACP Online
Annals of Internal Medicine Annals of Internal Medicine Enter words / phrases / DOI / ISBN …
Annals of Internal Medicine Annals of Internal Medicine Enter words / phrases / DOI / ISBN …
Adherence to antiretroviral therapy by human immunodeficiency virus—infected patients
BJ Turner - The Journal of infectious diseases, 2002 - academic.oup.com
Poor adherence to antiretroviral treatment regimens has serious consequences for human
immunodeficiency virus—infected patients, including failure to prevent viral replication and …
immunodeficiency virus—infected patients, including failure to prevent viral replication and …
Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice
KH Mayer, VE Stone - Clinical Infectious Diseases, 2001 - academic.oup.com
Successful treatment of human immunodeficiency virus infection/acquired immunodeficiency
syndrome (HIV/AIDS) with highly active antiretroviral therapy (HAART) requires that patients …
syndrome (HIV/AIDS) with highly active antiretroviral therapy (HAART) requires that patients …